Fluorotechnics Expands Global Capability via Acquisition of ETC Elektrophorese-Technik
News Nov 14, 2007
Fluorotechnics has announced the acquisition of ETC Elektrophorese-Technik. Under the terms of the acquisition, Fluorotechnics will acquire all issued shares in ETC Elektrophorese-Technik in exchange for Fluorotechnics shares.
ETC Elektrophorese-Technik develops and manufactures high-end electrophoresis consumables and equipment used for diagnostics, quality control and species identification. Fluorotechnics is a developer and manufacturer of fluorescent research tools that are used in proteomics, cell biology and biochemistry.
Fluorotechnics CEO, Duncan Veal, states,” We are very excited by the synergies that the combination of the two companies will bring. This acquisition will allow us to cross-sell products to existing customers and to address new markets utilizing our joint expertise. Our ever-expanding sales and marketing team and enormous potential for our product offering means that we are well positioned for strong growth.”
Hanspeter Schickle, CEO of ETC, said,” We know that our customers will welcome the extended offering and complete solution that the range of Fluorotechnics and ETC products will now provide. The merged group possesses exceptional expertise, has a dynamic product pipeline and is set to become a leading supplier to life-scientists, globally.”
There are hundreds of thousands of structural variants (SVs) in the human genome that are hard to identify than single nucleotide variants. Researchers have used a full suite of genomic technologies to analyze the number of SVs in three individuals, and the results present as the most comprehensive catalog of SVS to date.READ MORE